The proteins belonging to the WhiB superfamily are small global transcriptional regulators typical of actinomycetes. In this paper, we characterize the role of WhiB5, a Mycobacterium tuberculosis protein belonging to this superfamily. A null mutant was constructed in M. tuberculosis H37Rv and was shown to be attenuated during both progressive and chronic mouse infections. Mice infected with the mutant had smaller bacillary burdens in the lungs but a larger inflammatory response, suggesting a role of WhiB5 in immunomodulation. Most interestingly, the whiB5 mutant was not able to resume growth after reactivation from chronic infection, suggesting that WhiB5 controls the expression of genes involved in this process. The mutant was also more sensitive than the wild-type parental strain to S-nitrosoglutathione (GSNO) and was less metabolically active following prolonged starvation, underscoring the importance of GSNO and starvation in development and maintenance of chronic infection. DNA microarray analysis identified 58 genes whose expression is influenced by WhiB5, including sigM, encoding an alternative sigma factor, and genes encoding the constituents of two type VII secretion systems, namely, ESX-2 and ESX-4.
P
roteins belonging to the WhiB superfamily are typical of actinomycetes (36) . They are small cytoplasmic proteins that contain four conserved cysteine residues able to coordinate an Fe-S cluster (8) . They were first described for Streptomyces as redoxsensing transcriptional regulators involved in sporulation, differentiation, and antibiotic production (8) . The demonstration of their DNA-binding activity is very recent (33) .
The Mycobacterium tuberculosis genome encodes 7 proteins belonging to this superfamily. All of them have a CXXC motif similar to that found in thioredoxins and other oxidoreductases, with the exception of WhiB5, which has a CXXXC motif (2) .
M. tuberculosis WhiB-like proteins, with the exception of WhiB2, were recently proposed to have protein disulfide reductase activity (2) , suggesting that they might represent bifunctional proteins able to bind either DNA to regulate transcription or specific target proteins to modify their activity by reducing specific intramolecular disulfides (15) .
Of the seven WhiB-like proteins of M. tuberculosis, only four (WhiB1, WhiB2, WhiB3, and WhiB7) have been studied extensively. Almost nothing is known regarding the others (WhiB4, WhiB5, and WhiB6), beyond their expression profiles (16) and their protein disulfide reductase activity (2) . WhiB1 was recently shown to be an essential protein that is able to repress its own transcription by binding to the promoter region of its structural gene (35) . It was also shown to interact with GlgB [alpha(1,4)-glucan branching enzyme] and to reduce an intramolecular disulfide bond present in this protein, suggesting a role in posttranslational regulation of GlgB (15) .
WhiB2, also named WhmD, is encoded by an essential gene and is involved in cell division. A conditional mutant of this gene in M. smegmatis was shown to produce filamentous cells under nonpermissive conditions (27, 28) . Recently, both WhiB2 and a WhiB2 homolog encoded by a mycobacteriophage were shown to bind the whiB2 promoter to inhibit its transcription (32) .
WhiB3 was shown to interact with SigA, the principal sigma factor of M. tuberculosis (37) . It is able to respond to dormancy signals, including O 2 and nitric oxide (NO), through its Fe-S cluster (34) , and it represents an intracellular redox sensor able to integrate environmental signals with the metabolic pathways responsible for the biosynthesis of complex lipids such as poly-and diacyltrehalose, sulfolipids, phthiocerol dimycocerosate, and triacylglycerol. Through this mechanism, WhiB3 contributes to the maintenance of intracellular redox homeostasis by channeling toxic reducing equivalents into lipid anabolism (33) .
Finally, WhiB7 confers low levels of resistance to several antibacterial drugs, and its structural gene is induced in their presence. Its overexpression was shown to induce the expression of genes involved in ribosomal protection and antibiotic efflux (23) .
In this paper, we focus on M. tuberculosis WhiB5. An ortholog of this protein is encoded in the chromosomes of all members of the M. tuberculosis complex as well as in those of several slow-and fast-growing mycobacteria, such as Mycobacterium ulcerans, Mycobacterium marinum, Mycobacterium avium, and Mycobacterium kansasii. However, WhiB5 is not encoded in the genomes of My-cobacterium leprae and Mycobacterium smegmatis. We showed that WhiB5 is involved in metabolic regulation during starvation and is necessary for full virulence during progressive infection and for the ability of M. tuberculosis to reactivate after chronic infection. Moreover, using DNA microarrays, we identified 58 genes belonging to the WhiB5 regulon.
MATERIALS AND METHODS

Ethics statement. Animal studies were approved by the Institutional Ethics Committee of the National Institute of Medical Sciences and Nutrition Salvador Zubiràn in accordance with the Mexican national regulations on animal care and experimentation (NOM 062-ZOO-1999).
Bacterial strains, media, and growth conditions. The strains used and generated in this work are listed in Table 1 . All experiments were performed with M. tuberculosis H37Rv. Bacteria were grown in Middlebrook 7H9 broth or 7H10 agar medium supplemented with 0.05% Tween 80, 0.2% glycerol, and 10% albumin-dextrose-NaCl (ADN) or oleic acid-albumin-dextrose-catalase (OADC) (Difco) at 37°C. Liquid cultures were incubated in rolling bottles with gentle rotation. Plates were incubated at 37°C in sealed plastic bags. Escherichia coli DH5␣ (Invitrogen) was grown in Luria broth (Difco) at 37°C. Where necessary, streptomycin was added at 20 g/ml, hygromycin (Hyg) was added at 50 g/ml (M. tuberculosis) or 150 g/ml (E. coli), or kanamycin was added at 20 g/ml (M. tuberculosis) or 50 g/ml (E. coli). Pristinamycin I (Sanofi-Aventis, Paris, France) was dissolved in dimethyl sulfoxide (DMSO) (50 mg/ml) and used at 1 g/ml.
DNA manipulations and electroporation. Plasmids used in this work are shown in Table 2 . Recombinant DNA techniques were performed according to standard procedures, using E. coli DH5␣ as the initial host. DNA restriction and modifying enzymes were obtained from New England BioLabs and used according to the manufacturer's suggestions. Preparation of electrocompetent cells and electroporation were performed as previously described (20) . Primers used in the study are shown in Table S1 in the supplemental material.
Construction of an M. tuberculosis strain with an inducible copy of whiB5. Overexpression of whiB5 in M. tuberculosis was achieved using a pristinamycin-inducible expression system based on the Streptomyces pristinaespiralis ptr promoter and its pristinamycin-responsive negative repressor, Pip (14) . The whiB5 sequence was amplified from M. tuberculosis H37Rv genomic DNA and cloned downstream of P ptr in the integrative vector pMYT769 to obtain pMYT790 ( Table 2) . The vector was then introduced into M. tuberculosis H37Rv. The efficiency of the system was verified by reverse transcriptase PCR (RT-PCR) in the presence or absence of induction by pristinamycin (1 g/ml).
Construction of a whiB5 null mutant in M. tuberculosis. An M. tuberculosis mutant lacking whiB5 was constructed using recombineering (39) . For this purpose, a cassette conferring Hyg resistance flanked by two DNA fragments of about 500 bp flanking the whiB5 gene was electroporated into an M. tuberculosis strain containing the plasmid pJV53, encoding phage recombinases (40) ( Table 2) , and transformants were selected on Hyg. Two mutants were selected and analyzed by PCR. pJV53 was cured to recover the whiB5 mutant strain TB15. The mutant was then complemented by introducing the integrative plasmid pSC25, containing whiB5 and its upstream region containing the native promoter. The complemented strain was named TB16.
Bacterial two-hybrid assay. DNA fragments encoding the 4.2 domain of SigA (176 bp) (37), WhiB3 (329 bp), and WhiB5 (422 bp) were amplified from M. tuberculosis H37Rv chromosomal DNA. The sigA fragment was cloned into pKT25, and whiB3 and whiB5 were cloned into pUT18c, to create 3= in-frame fusions with sequences encoding the Bordetella pertussis CyaA T25 domain (pKT25::4.2sigA) and T18 domain (pUT18c:: whiB3 and pUT18c::whiB5) (19) . pKT25::4.2sigA was cotransformed with either pUT18c::whiB3 or pUT18c::whiB5 into E. coli BTH101, and transformants were selected on solid medium at 28°C with appropriate selection. The resulting strains were analyzed by a ␤-galactosidase assay. A }/OD 600 ϫ min of incubation ϫ cell volume (ml).
Determination of growth inhibition by disk diffusion assay. M. tuberculosis strains were grown to early exponential phase, and 100 l of culture containing 3 ϫ 10 6 CFU was spread on 20-ml 7H10 plates. Paper disks containing 10 l of the following stock solutions were placed on top of the agar: 5 mM sodium nitroprusside, 0.5 M EDTA, 2 M diamide, 30% (wt/wt) hydrogen peroxide in water, 35 mM cumene hydroperoxide, and 100% ␤-mercaptoethanol. The diameter of the inhibition zone was measured after 15 days of incubation at 37°C.
Determination of GSNO resistance. M. tuberculosis strains were grown in 7H9 broth to mid-log phase and then diluted to an OD 600 of approximately 0.1. The bacterial suspensions were then treated with 1 mM S-nitrosoglutathione (GSNO; Sigma) or left untreated. The OD 600 was measured at different time points. Each day, an aliquot was taken from each sample, diluted, and plated on 7H10 plates for determination of the viable counts. All experiments were performed three times in triplicate.
Determination of metabolic activity during starvation. Cultures grown for 7 days in 7H9 broth were pelleted, washed twice with phosphatebuffered saline (PBS), and then resuspended in PBS. The resulting samples were incubated without agitation at 37°C in sealed bottles. Metabolic activity was determined at several time points by using a 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay (3). Briefly, 200 M XTT and 60 M menadione were added to 250 l of M. tuberculosis suspension and incubated for 40 min at 37°C before reading of the absorbance at 450 nm.
RNA extraction and preparation of labeled cDNA for DNA microarray analysis. RNA extraction from in vitro-cultured M. tuberculosis was performed as previously described (20) , and RNAs were analyzed using an Agilent Bioanalyser 2100 system (Agilent Technologies) according to the manufacturer's instructions.
Fluorescently labeled cDNA copies of total RNA were prepared by direct incorporation of fluorescent nucleotide analogues during a firststrand reverse transcription reaction (25) .
Microarray hybridization and data analysis. M. tuberculosis oligoarrays consisting of 4,295 70-mer oligonucleotides representing 3,924 open reading frames (ORFs) from M. tuberculosis strain H37Rv and 371 unique ORFs from strain CDC 1551 that are not present in H37Rv were obtained from the Center for Applied Genomics, International Center for Public Health (Newark, NJ).
Competitive hybridizations with equal amounts of purified Cy3-and Cy5-labeled cDNA were performed in duplicate with both dye arrangements, as previously described (25) .
Microarrays were scanned using an Agilent G2565CA microarray scanner system (with Scan Control 8.1 software [Agilent Technologies]), and fluorescence intensities of the two channels at each spot were quantified using Agilent Feature Extraction 10.1 software (Agilent Technologies).
Data were normalized with the Web-based tool DNMAD (diagnosis and normalization of spotted cDNA microarray data [http://dnmad .bioinfo.cnio.es/]) (41), using the print-tip lowess method after background subtraction. Genes significantly differentially expressed were identified using the significance analysis of microarrays (SAM) tool (38) . Differentially expressed genes were defined by a q value of 0% and a minimum fold difference of Ϯ2-fold between the two samples. SAM is part of the Tiger MultiExperiment Viewer package, version 4.6 (TMeV), available at http://www.tm4.org/mev/ (26).
RACE. Transcription start points (TSPs) of selected genes were determined by rapid amplification of cDNA ends (RACE), using a 5=/3= RACE kit (Roche Applied Science) according to the manufacturer's suggestions. Primer sequences are shown in Table S1 in the supplemental material.
Analysis of the whiB5 promoter region. The whiB5 promoter region was amplified from H37Rv genomic DNA and cloned into pCR-Blunt II-TOPO (Invitrogen) to obtain pSC31. The fragment was then excised as a HindIII/NheI fragment and cloned upstream of the gfp gene in pMV4-36 (7) to obtain pSC43 ( Table 2) .
M. tuberculosis cells containing pSC43 were washed and resuspended in lysis buffer (10 mM Tris-HCl [pH 8], 5 mM EDTA, 1ϫ protease inhibitor cocktail [Roche] ) with an appropriate volume of 0.1-mm zirconia beads. Cells were disrupted using a Mini-Bead Beater apparatus with three cycles of 30 s each at the highest speed. Samples were centrifuged for 2 min, and the supernatants were recovered and filter sterilized. The fluorescence of cell extracts was measured with a Perkin Elmer LS50B spectrophotometer with excitation at 480 nm and emission at 510 nm. Protein concentrations were determined using a Bradford protein assay kit (BioRad). Fluorescence readings were then normalized for the protein concentration and expressed as the relative fluorescence per mg of total proteins present in the extract.
Infection of THP-1-derived macrophages. THP-1 monocytes (American Type Culture Collection) were grown in suspension at 37°C in 5% CO 2 in bicarbonate-buffered RPMI (Gibco) supplemented with 10% (vol/vol) fetal bovine serum (FBS) (Gibco), 50 mol/liter ␤-mercaptoethanol, and 50 g/ml gentamicin at a cell density of 0.2 ϫ 10 6 to 1.0 ϫ 10 6 /ml. Cells were plated at a density of 7.5 ϫ 10 4 cells/well in RPMI with 10% FBS, 50 mol/liter ␤-mercaptoethanol, 50 g/ml gentamicin, and 50 ng/ml phorbol 12-myristate 13-acetate (PMA) (Sigma) for 24 h to become fully differentiated macrophages before use in experiments. Differentiated THP-1 macrophages were washed extensively with serum-free RPMI and infected with M. tuberculosis in 96-well plates at a multiplicity of infection of 1:20 (CFU:macrophages) (22) . After 90 min of incubation at 37°C, the medium was removed and cells were washed twice with 100 l of warm PBS to remove extracellular bacteria. The medium was replaced every 48 h. Every 24 h for 8 days, starting from 90 min after the initial washes, the medium was removed from three wells, and then intracellular bacteria were released by lysing the macrophages with 100 l of 0.05% SDS. The suspensions obtained from the lysed macrophages were immediately diluted in 7H9 broth and plated to determine viable counts. About 95% of macrophages remained viable during the entire experiment, as determined by trypan blue exclusion.
Mouse infection and RNA extraction from lung homogenates during experimental progressive and chronic tuberculosis infections. To induce progressive pulmonary tuberculosis, male BALB/c mice were anesthetized, tracheas were exposed, and 2 ϫ 10 5 viable bacilli were injected (17) . Groups of 4 mice were killed at different time points after infection.
To induce chronic infection, 8-week-old B6D2F1 mice were anesthetized, and 4 ϫ 10 3 bacilli were instilled intratracheally (4). Groups of 3 mice in 2 different experiments were euthanized at different time points.
RNAs were extracted from the lungs of infected mice by use of a previously described protocol (9), with some modifications. Briefly, lungs from three mice for each time point were perfused with 1 ml of TRIzol (Qiagen, Valencia, CA). The tissue was minced, transferred to a sterile tube, and homogenized using a Multi-Gen 7 homogenizer (Pro Scientific) for three cycles in 30-s bursts at maximal speed. The homogenized samples were centrifuged at 4,000 rpm for 10 min at 20°C, and the supernatant was transferred to a new tube and immediately placed on ice. This supernatant contained eukaryotic RNA, whereas the pelleted material con-tained the bacilli. To isolate the bacterial RNA, pellets were resuspended in 1 ml of TRIzol and transferred to a 2-ml screw-cap tube containing zirconia and silica beads (1-and 0.1-mm diameter, respectively). Mycobacteria were disrupted using a Mini-Bead Beater 8 apparatus (Biospec Products Inc.), using three cycles of 30 s each at the highest speed. This material was then centrifuged for 1 min at maximum speed, and the supernatant was transferred to a 2-ml screw-cap tube containing 300 l of chloroform. After vigorous vortexing and centrifugation for 10 min at maximum speed, the resulting supernatant, containing the M. tuberculosis RNA, was precipitated with a solution of glycogen, ammonium acetate, isopropanol, and ethanol. Finally, bacterial RNA was isolated using four cycles of purification with an RNeasy column (Invitrogen), followed by extensive DNase incubation to eliminate DNA contamination.
Mouse infection for determination of virulence and immunogenicity in experimental models of progressive and chronic infections. The murine models described above were used to compare the levels of virulence and types of immune response induced by infection with the whiB mutant and the complemented and parental strains.
To induce acute progressive infection, 6-to 8-week-old BALB/c male mice were distributed in three groups of 60 animals each and infected with each of the different strains, using a high dose (2 ϫ 10 5 cells) of viable bacilli to induce progressive disease. Ten mice from each group were left undisturbed to record survival from day 8 to day 120 after infection. Six animals from each group were sacrificed by exsanguination 1, 3, 7, 14, 21, 28, 60, and 120 days after infection. One lung lobe, the right or left, was perfused with 10% formaldehyde dissolved in PBS and prepared for histopathological studies. The other lobe was snap-frozen in liquid nitrogen and then stored at Ϫ70°C for microbiological and immunological analysis.
To induce chronic infection, three groups of 50 female B6D2F1 mice each were infected with either of the three strains, using a low-dose inoculum (4 ϫ 10 3 cells). Groups of 6 mice in 2 different experiments were euthanized 1, 3, and 5 months after infection. To induce reactivation, 10 mice with stable chronic infection at 5 months of infection were treated with corticosterone (3 mg/liter dissolved in drinking water) and then sacrificed 1 month later. One lung was perfused with 10% formaldehyde dissolved in PBS and prepared for histopathological studies. The other lobe was snap-frozen in liquid nitrogen and then stored at Ϫ70°C for microbiological and immunological analysis.
Preparation of lung tissue for histology and automated morphometry. For histology and automated morphometry analysis, one lobe of the lung was fixed by intratracheal perfusion with 10% formaldehyde for 24 h, sectioned through the hilus, and embedded in paraffin. Sections (5 m thick) were stained with hematoxylin-eosin and used to determine the percentage of the pulmonary area affected by pneumonia and the granuloma area (in square micrometers), using an automated image analyzer (Q Win Leica, Milton Keynes, United Kingdom) (18) . The same paraffin-embedded material prepared for histopathological studies was used to determine the local cytokine production by immunohistochemistry. Lung sections from mice infected with either the mutant or parental strain in the model of progressive disease, taken at days 28, 60, and 120, were deparaffinized and maintained in 1ϫ HCN buffer (HEPES, NaCl, and CaCl 2 ). Sections were washed with 1ϫ HCN plus 0.05% Tween 20, and the endogenous peroxidase activity was blocked with 6% H 2 O 2 dissolved in 1ϫ PBS plus 0.1% sodium azide and incubated for 1 h. After blocking with normal swine serum, tissue sections were incubated with primary antibodies overnight at 4°C at optimal dilutions, which had been determined previously. We used primary antibodies against tumor necrosis factor alpha (TNF-␣) (rabbit polyclonal IgG clone H-156; Santa Cruz Biotechnology), gamma interferon (IFN-␥) (goat polyclonal IgG clone D-17; Santa Cruz Biotechnology), transforming growth factor beta (TGF-␤) (rabbit polyclonal IgG; Santa Cruz Biotechnology), interleukin-4 (IL-4) (goat polyclonal IgG; Santa Cruz Biotechnology), and IL-10 (goat polyclonal IgG clone M-18; Santa Cruz Biotechnology). Secondary biotinylated antibodies (biotin-anti-rabbit IgG or biotin-anti-goat IgG) were used to detect the binding of the primary antibodies. Finally, horseradish peroxidase (HRP)-conjugated avidin and 3,3-diaminobenzidine (DAB)-hydrogen peroxide were used to develop the reaction. Tissue sections were counterstained with hematoxylin. For morphometry, at least three random fields from each section for three different mice for each time point and each strain were studied. The total number of inflammatory cells, specifically in the area of pneumonia and in granulomas, was quantified, and the percentage of cytokine-immunostained cells or positive cells for each cytokine was determined using an automated image analyzer (Q Win Leica).
Determination of CFU in infected lungs. Right or left lungs from four mice for each time point in two separate experiments were used for colony counting (CFU). Lungs were homogenized with a Polytron homogenizer (Kinematica, Lucerne, Switzerland) in sterile 50-ml tubes containing 3 ml of isotonic saline. Four dilutions of each homogenate were spread onto duplicate plates containing Bacto Middlebrook 7H10 agar enriched with OADC. Plates were incubated for 21 days prior to determination of CFU.
Real-time PCR analysis. Reverse transcription was performed with random primers and murine leucoblastoma virus retrotranscriptase (MULV RT) (Applied Biosystems). Five hundred nanograms of total RNA was denatured at 98°C for 2 min and then chilled on ice and used to prepare 25 l of annealing mixture (5.5 mM MgCl 2 , a 0.55 mM concentration of each deoxynucleoside triphosphate [dNTP], 0.25 mmol random hexamers, 32 U of MULV RT, 10 U of RNase inhibitor, and 1ϫ reaction buffer [Applied Biosystems]). Samples were then incubated at 25°C for 10 min, at 45°C for 50 min, and finally at 95°C for 5 min to allow annealing of the random hexamers. Quantitative PCR was performed with SYBR green master mix (Applied Biosystems) as previously described (20) . For bacterial mRNA analysis, results were normalized to the amount of sigA mRNA or 16S rRNA (21) . RNA samples that had not been reverse transcribed were included in all experiments to monitor DNA contamination. For analysis of cytokines in lung homogenates, left or right lung lobes from three different mice per group in two different experiments were used to isolate mRNA by use of an RNeasy miniprep kit (Qiagen) according to the recommendations of the manufacturer. Quality and quantity of RNA were evaluated through spectrophotometry and on agarose gels. The mRNA encoding glyceraldehyde 3-phosphate dehydrogenase (G3PDH) was used as an internal control to normalize the expression of the cytokine-expressing genes. Data are shown as numbers of copies of cytokine-specific mRNA/10 6 copies of G3PDH-specific mRNA (18) .
Microarray data accession number. The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (12) and are accessible through GEO Series accession number GSE30299 (http: //www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accϭGSE30299).
RESULTS
A whiB5 null mutant shows normal growth on laboratory media and in macrophages. To study the physiological role of WhiB5, recombineering (40) was used to replace its structural gene with a cassette conferring resistance to hygromycin. The resulting mutant strain (TB15) showed growth kinetics and colony morphology indistinguishable from those of the wild-type (wt) strain in Middlebrook 7H9 or 7H10 medium (data not shown). Finally, the TB15 mutant was complemented by reintroducing the whiB5 gene with its upstream regulatory region at an ectopic locus of its chromosome, giving strain TB16.
M. tuberculosis is a facultative intracellular pathogen that can survive and grow inside macrophages. To investigate whether WhiB5 was dispensable for intraphagosomal growth, we infected THP-1-derived macrophages with exponentially growing cultures of H37Rv and the whiB5 mutant TB15. As shown in Fig. 1 , both strains were able to divide intracellularly during the entire course of the experiment (6 days), with their CFU increasing about 100-fold. No difference between the two strains was observed, suggesting that WhiB5 is not required for intracellular growth in resting macrophages.
Characterization of whiB5 mutant immunopathogenicity during experimental progressive tuberculosis. To characterize the role of WhiB5 during experimental progressive tuberculosis, three groups of BALB/c mice (60 per group) were infected intratracheally with 2.5 ϫ 10 5 CFU of either H37Rv, the whiB5 mutant TB15, or the complemented derivative TB16. Ten animals from each group were left undisturbed until the end of the experiment (120 days). Among them, all of the animals infected with TB15 survived, while seven of those inoculated with the parental strain died. However, only 3 of the 10 animals infected with the complemented strain TB16 died before the end of the experiment, indicating partial complementation (Fig. 2A) . These data correlated well with the bacterial burdens in lung homogenates (Fig. 2B) . After 1 week of infection and thereafter, a small but statistically significant difference in bacterial loads was found in the lungs of mice infected with the whiB5 mutant compared to those of the animals infected with the parental or complemented strain. Histopathological analysis showed progressive pneumonia after 28 days of infection with H37Rv, reaching its peak at day 120, when 50% of the lung surface was affected. Although the lungs of mice infected with the whiB5 mutant TB15 showed significantly smaller bacterial loads, the percentage of lung consolidation in these animals was similar to that observed for mice infected with the parental strain (Fig. 3A and B) . The size of granulomas, which appeared 2 weeks after infection, was about 2-fold larger in mice infected with the whiB5 mutant than in mice infected with the wt or complemented strain (Fig. 2C and 3A and B) . These data suggested that the whiB5 mutant was able to induce a strong inflammatory response. This was confirmed by the data shown in Fig. 4 , which demonstrate higher expression levels of IFN-␥, TNF-␣, and inducible nitric oxide synthase (iNOS) in the lungs of mice infected with the mutant strain than in those of mice infected with the parental or complemented strain. Expression of IL-4, however, was lower in the lungs of mice infected with the mutant strain. These results were confirmed and extended at the protein production level by use of immunohistochemistry and automated morphometry. Figure 3C to F show cells producing IFN-␥ (C and D) or IL-10 (E and F) in granulomas of mice infected with the whiB5 mutant TB15 (C and E) or the parental strain H37Rv (D and F). Quantitative analysis of immunostained cells clearly showed significantly higher percentages of TNF-␣-and IFN-␥-producing cells and smaller amounts of IL-4-, IL-10-, and TGF-␤-producing cells in the lungs of mice infected with the mutant strain than in those of mice infected with the parental strain. The situation was similar in the area of pneumonia and in granulomas (Fig. 5) .
Characterization of whiB5 mutant immunopathogenicity during chronic infection. The role of WhiB5 in M. tuberculosis virulence was also investigated during experimental chronic tuberculosis. Three groups of B6D2F1 mice (50 per group) were infected intratracheally with 4.0 ϫ 10 3 CFU of either H37Rv, the whiB5 mutant TB15, or the complemented strain TB16. As expected, all animals were alive after 5 months of infection and had very small amounts of bacteria in their lungs (Fig. 6) . While the bacterial burdens in the lungs of mice infected with the whiB5 mutant TB15 were slightly lower than those detected in the lungs of mice infected with H37Rv or the complemented strain TB16, mice infected with the whiB5 mutant showed higher levels of cytokine mRNA (with the exception of that for TNF-␣) (Fig. 7) and similar inflammation to that observed in mice infected with the parental or complemented strain (data not shown).
After 5 months of chronic infection, 10 mice from each group were treated with corticosterone to induce immunosuppression and infection reactivation. After 1 month of immunosuppression, all TB15-infected animals and 9 of 10 of the animals infected with the parental or complemented strain were still alive. Survivors were sacrificed, and the bacterial burden in the lung was determined: animals infected with the wt or the complemented strain showed a sharp increase in the number of CFU in the lungs, while the bacterial burden did not change significantly in whiB5 mutant-infected mice, suggesting that these animals were still able to control the infection (Fig. 6 ). Taken together, these data clearly indicate that WhiB5 contributes to the reactivation of chronic tuberculosis in this model system.
Expression of whiB5 during progressive and chronic infections. Given the role of WhiB5 in M. tuberculosis virulence and reactivation, we measured the transcription of its structural gene during active and chronic infections with the wild-type strain H37Rv, using quantitative RT-PCR (with results expressed as the number of whiB5 cDNA copies/10 6 16S cDNA copies). As shown in Fig. 8A , whiB5 expression during progressive infection was at its maximum between day 14 and day 28. However, during chronic infection, whiB5 showed low and stable expression throughout the experiment, with increased expression during reactivation (Fig. 8B) .
Sensitivity of the whiB5 mutant to environmental stress. To investigate the specific role of WhiB5 in M. tuberculosis physiology, we tested the relative resistance of H37Rv and the whiB5 mutant TB15 to different stresses mimicking the environments encountered by bacilli during active or chronic infection. Resistance to hydrogen peroxide, cumene hydroperoxide (an organic peroxide), sodium nitroprusside and acidified nitrate (both of which are nitric oxide [NO] donors), EDTA, and ␤-mercaptoethanol was tested using a disk diffusion assay on agar plates or by examining the killing curve for liquid medium. However, we could not observe any differences in sensitivity to these six compounds among the strains tested (data not shown). Since previous work had shown that whiB5 was slightly induced in the presence of GSNO (6), we tested the sensitivity of the mutant strain to this compound. As shown in Fig. 9 , during exposure to a GSNO concentration of 1 mM, the wt strain was still able to proliferate, while the whiB5 mutant's growth was arrested. The wt phenotype was partially restored in complemented strain TB16. Role of WhiB5 in the level of metabolic activity during starvation. During chronic infection, it is hypothesized that bacilli are exposed to an environment that is poor of nutrients. In order to demonstrate whether WhiB5 might have a physiological role during starvation, the metabolic activity of the wt, mutant, and complemented strains was measured using XTT (a compound which exhibits a color change when reduced to a formazan product by an active electron transport chain) during prolonged incubation in PBS. This method was previously used to evaluate the metabolic activity of M. avium in response to starvation (3) . As shown in Fig.   FIG 3 Representative lung histopathology and immunohistochemistry of BALB/c mice after 60 days of infection with the whiB5 mutant TB15 (left panels) or the parental strain (right panels). (A and B) Similar areas of pneumonia were induced by either strain (asterisks), while larger granulomas (arrows) were produced by strain TB15. Granulomas from mice infected with TB15 (C) showed a larger amount of IFN-␥-immunostained cells than granulomas from animal infected with the parental strain (D). However, granulomas in the lungs of mice infected with the mutant strain TB15 (E) exhibited fewer IL-10-immunostained cells than granulomas of mice infected with the parental strain (F). Magnification, ϫ100 (A and B) and ϫ200 (C to F). Panels A and B show H&E staining, and panels C to F show HRP-developed immunohistochemistry.
10, after 2, 3, and 4 weeks of incubation in PBS, the mutant strain TB15 showed significantly less reducing power than the wt and complemented strains, suggesting a lower metabolic activity. Viability of the three strains, however, did not show any significant difference during the experiment (data not shown). We finally analyzed the ability of the whiB5 mutant to grow using different carbon sources. For this purpose, bacteria were grown in Dubos medium containing 50 mM glucose, succinate, fumarate, pyruvate, or citrate or 25 mM acetate as the principal carbon source, and growth was monitored for 6 weeks. No differences between the strains were observed, showing that WhiB5 is not involved in the utilization of these different carbon sources (data not shown).
Identification of WhiB5-regulated genes. Preliminary DNA microarray experiments comparing the global transcriptional profiles of the mutant and wt strains in the exponential phase of growth did not reveal any statistically significant differences, suggesting that in the absence of a specific environmental signal, WhiB5 does not play any relevant role in transcriptional regulation (data not shown). For this reason, we decided to repeat the experiments by using a strain in which the expression of whiB5 was placed under the control of a chemically inducible promoter. For this purpose, we constructed a strain in which whiB5 was transcribed from the tightly regulated P ptr promoter (14) . whiB5 was cloned in frame with the P ptr promoter in the integrative plasmid pMYT769 (14) , encoding the Streptomyces pristinaespiralis regulator Pip (13) , to obtain the plasmid pMYT790. This plasmid was introduced into M. tuberculosis H37Rv to generate the recombinant strain TB84. In the absence of pristinamycin I, Pip binds to P ptr operators, repressing whiB5 transcription; addition of the drug at subinhibitory concentrations, however, restores whiB5 transcription in a dose-responsive manner (14) .
The total RNAs of TB84 (containing the plasmid for whiB5 inducible expression) and TB60 (containing the empty vector), both grown in the presence of pristinamycin I (1 g/ml) for 15 min or 3 h, were compared on whole-genome DNA microarrays. whiB5 induction for 15 min resulted in the induction of 26 genes, while induction for 3 h resulted in the induction of 58 genes (see Table S2 in the supplemental material). All 26 genes induced after 15 min remained induced after 3 h of incubation with pristinamycin I. Interestingly, most of the identified genes fell into one of five clusters on the chromosome. The induction of representative genes was successfully confirmed by quantitative RT-PCR (see Table S2 ). Induction of whiB5 resulted in increased expression of the gene encoding the alternative ECF sigma factor SigM and at least 12 genes known to be part of its regulon, including those encoding the ESX-4 type VII secretion system. Interestingly, the genes encoding the ESX-2 type VII secretion system were also strongly induced.
Identification of the transcriptional start points of WhiB5-regulated genes. The TSPs of three representative genes belonging to the WhiB5 regulon and not regulated by SigM (Rv2078, Rv1951, and Rv3891c) (1, 30) were identified by 5= RACE (Fig.  11) . Based on analysis of their upstream regions, we could identify conserved putative Ϫ10 and Ϫ35 regions, thus suggesting a similar regulation. We also determined the whiB5 TSP: in its upstream region, we found a sequence matching the Ϫ10 region found upstream of the other genes, located only 4 bases from the TSP. However, no significant similarity was detected in the Ϫ35 region (Fig. 11) .
whiB5 transcription is autoregulated. WhiB1 and WhiB2 are known to be autoregulated (32, 35) . To determine whether WhiB5 can also directly or indirectly regulate transcription of its own structural gene, we constructed a replicative plasmid in which the whiB5 upstream region containing its promoter was transcriptionally fused to a promoterless green fluorescent protein (GFP)-encoding gene. This plasmid was introduced into both H37Rv and the whiB5 mutant TB15. The resulting strains were grown in 7H9 medium, and after 24 or 48 h of incubation, bacteria were lysed to measure fluorescence (which was normalized to the level of proteins in the extract). As shown in Fig. 12 , the activity of the whiB5 promoter region was clearly higher in TB15 than in the wt strain, strongly suggesting that WhiB5 is able to negatively regulate the transcription of its own structural gene.
WhiB5 does not interact with the 4.2 subregion of SigA. Since WhiB3 exerts its action by interacting with the 4.2 subregion of SigA (37), we took a direct approach to determine if WhiB5 is also able to bind this SigA subregion. For this purpose, we used an E. coli two-hybrid system based on reconstitution of the catalytic domain of the B. pertussis adenylate cyclase CyaA, formed by the 
FIG 6
Pathogenicity of the whiB5 mutant during chronic infection following low-dose intratracheal inoculation. Lung bacterial burdens were determined for mice infected with M. tuberculosis H37Rv (black), the whiB5 mutant TB15 (light gray), or the complemented strain TB16 (dark gray). After 5 months of infection, mice were treated with corticosterone to allow reactivation. Mice were sacrificed at 1, 3, 5, and 6 months postinfection. two independently folding domains T18 and T25 (19) . We previously used this system to determine the interaction between SigE and its anti-sigma factor RseA (10). The 4.2 subregion of SigA was fused to the C terminus of T25 (T25-SigA), while either WhiB5 or WhiB3 was fused to the C terminus of T18 (T18-WhiB5 and T18-WhiB3). The amount of ␤-galactosidase activity (due to reconstitution of the CyaA catalytic domain) in E. coli BTH101 cultures coexpressing T25-SigA and T18-WhiB3 was about 4-fold higher than the background level, while the activity in cells coexpressing T25-SigA and T18-WhiB5 was equal to the background level, suggesting that WhiB5, unlike WhiB3, does not interact with the 4.2 subregion of SigA (data not shown).
DISCUSSION
In this paper, we characterized WhiB5, a member of the WhiB-like family of regulators in M. tuberculosis, studying its role in global regulation of gene expression, in response to stress, and during progressive and chronic infections.
Since preliminary DNA microarray experiments comparing the global transcriptional profiles of mutant and wt strains in the exponential phase of growth did not revealed any statistically significant differences, we repeated the experiments by using a strain in which the expression of whiB5 was placed under the control of a chemically inducible promoter. Under the conditions used for the experiments, the expression of whiB5 from the inducible promoter did not result in any difference in the growth of the bacteria (data not shown), excluding artifacts due to toxicity. A similar strategy was used previously to determine the regulon of WhiB7 (23) . The fact that whiB5 induction resulted in the increased expression of 58 genes and in no downregulated genes (see Table S2 in the supplemental material) underscores its role as a positive regulator of transcription, as already suggested for other members of this family of proteins (32, 35) , even if our experimental design did not allow us to discriminate between genes regulated directly or indirectly by WhiB5. Analysis of the transcriptional start sites of three genes belonging to its regulon revealed a conserved consensus promoter sequence that we hypothesize might include the region bound by WhiB5 (Fig. 11) . In support of this hypothesis, WhiB1 was recently shown to be able to protect a region encompassing the Ϫ10 and Ϫ35 regions of the promoter of its own structural gene (35) . A sequence similar to the Ϫ10 region of the whiB5 promoter was also found immediately upstream of the whiB5 TSP (position Ϫ4), a position not compatible with a role in whiB5 transcriptional initiation (Fig. 11) . Finally, we also demonstrated that the whiB5 promoter was expressed at higher levels in the whiB5 mutant, suggesting a mechanism of negative autoregulation (Fig. 12) . It is conceivable that binding of WhiB5 can either stimulate or repress transcription, depending on the position of its binding site relative to the TSP; however, we cannot exclude the involvement of another protein under the control of WhiB5.
WhiB3 binds the 4.2 subregion of SigA, the principal sigma factor of M. tuberculosis (37) , responsible for its interaction with the Ϫ35 hexamer (11) . Its interaction with WhiB3 suggested that this sigma factor might be involved in the recognition of promoters without a conserved Ϫ35 sequence or with a Ϫ35 sequence not directly recognized by the SigA 4.2 subregion. Using a bacterial two-hybrid approach, we confirmed the interaction between WhiB3 and the 4.2 subregion of SigA, but we could not demonstrate any interaction between this protein and WhiB5. Of course, since 4.2 domains are similar but not identical in all sigma factors, it remains possible that WhiB5 could interact with another of the 13 sigma factors of M. tuberculosis (31) . Since the WhiB5 regulon includes the gene encoding SigM (as shown by DNA microarrays [see Table S2 in the supplemental material]), this ECF sigma factor represents a good candidate for interaction with WhiB5.
In addition to the SigM gene, the WhiB5 regulon includes 12 genes previously shown to be under transcriptional control of SigM, such as those encoding the ESX-4 secreted proteins EsxT and EsxU and their orthologs EsxE and EsxF (see Table S2 in the supplemental material) (1, 29) . Genes upregulated by WhiB5 but not belonging to the SigM regulon included the entire gene cluster encoding the ESX-2 secretion system and several conserved genes of unknown function. Interestingly, if we exclude whiB5 and sigM, all of the genes of the WhiB5 regulon encode proteins of unknown function. A possible function can be hypothesized for a few of them, including two annotated ␣/␤ hydrolases (Rv2079 and Rv2542), a ferredoxin-like protein probably involved in electron transfer (FdxB), a transposase (Rv0031), and Mce4B, a member of a cholesterol uptake system (24) . This finding suggests that WhiB5 is involved in the regulation of still unknown physiological pathways.
It has been suggested that WhiB proteins are able to bind other proteins to modify their activity through their disulfide reductase function (2, 15) . In order to detect possible WhiB5 interactors, we recently used a yeast two-hybrid system to analyze an M. tuberculosis expression library, using WhiB5 as bait. The screen resulted in 27 positive hits (confirmed by retransformation) representing 13 different proteins (unpublished data). Among the most represented proteins, we found Rv0184 (5 hits), a cytoplasmic protein of unknown function, and the transposase Rv1199c (4 hits). Interestingly, a closely related transposase (Rv3640c) and the unrelated IS1547 transposase were also each selected twice during the screening. Alternative sigma factors were not represented. The lack of any predictable function for Rv0184 makes it impossible to speculate about the physiological relevance of this putative interaction. The interaction of WhiB5 with several transposases suggests that its function might have been hijacked from mobile genetic elements, which have an evolutionary advantage in inducing their mobility under conditions of stress endangering the bacterial host. It was recently demonstrated that the TM4 mycobacteriophage genome encodes a WhiB2-like protein whose role is to inhibit transcription of whiB2 during the early phase of infection, causing bacteriostasis, demonstrating a relationship between WhiB-like proteins and mobile genetic elements (32) . Further studies are needed to clarify the physiological role of the interaction of WhiB5 with these proteins.
In order to study the role of WhiB5 in pathogenesis, we mea- sured the expression of its structural gene during progressive and chronic infections. In the progressive disease model, when mice are infected with the H37Rv strain, the initial phase is dominated by high-level production of Th1 cell cytokines that, together with high levels of TNF-␣ and iNOS, temporarily control the infection. Granulomas develop during this phase, with maximal activity at day 21 postinfection. Four weeks after infection, the expression of Th1 cell cytokines, TNF-␣, and iNOS starts to decline. Gradually, pneumonic areas prevail over granulomas. Pneumonia in coexistence with a large bacterial burden causes death. The highest level of expression of whiB5 occurred from days 14 to 28 of infection, which corresponded to the higher activity of the protective immunity mediated by Th1 cytokines and activated macrophages (Fig.  8A ). This suggests that WhiB5 could be related to bacterial adaptation to the high-stress environment produced by the immune system. The expression of whiB5 was also measured in a murine model of chronic infection. This model is characterized by small and stable bacillary loads without weight loss or death of the animals. Histological and immunological studies showed granulomas with high expression of TNF-␣, IFN-␥, and iNOS (4). When corticosterone was supplied in drinking water to the infected animals, there was significant bacillary growth with development of lung consolidation, representing reactivation. In contrast to latent infection in humans, in the murine model the bacilli are not in a truly dormant state because they can be recovered in axenic culture (4). In this model, whiB5 in the wild-type strain showed low and stable expression and exhibited increased expression during reactivation (Fig. 8B) .
To characterize the physiological functions of WhiB5, we constructed a mutant of M. tuberculosis lacking the whiB5 gene. The mutant did not show any relevant growth difference with respect to the wt in broth culture or after exposure of bacteria to several different stress conditions or to intracellular growth in resting macrophages. However, we demonstrated that the mutant was more sensitive to GSNO than the wt parental strain (Fig. 9) . GSNO is converted into glutathione (GSH) and NO from bacterial thioredoxin (5) and is important in M. tuberculosis killing by activated macrophages (42) . While its mechanism of action against M. tuberculosis has not been elucidated fully, it might involve both the toxic action of NO and that of GSH. The latter is thought to provoke a redox imbalance involving the use of an alternative thiol that mycobacteria use for regulating reduction or oxidation activity (i.e., mycothiol). Alternatively, GSH could exert its inhibitory effect after being converted to the penicillin-like derivative glutacillin, a ␤-lactam form of GSH (42) . Our data showing sensitivity of our mutant to GSNO but not to two other NO donors (sodium nitroprusside and acidified nitrate) suggest that WhiB5 is involved in the response to the toxic action of GSH and not to that of NO.
We also found that the whiB5 mutant produced less reducing power (i.e., it is less metabolically active) than the wt parental strain during long periods of nutrient starvation (Fig.  10) , even though this did not affect its viability, suggesting that WhiB5 might be involved in sustaining the metabolic activity of M. tuberculosis during nutrient starvation. Both GSNO sensitivity and decreased reducing potential during starvation were partially complemented by the reintroduction of a wt copy of the gene, including its promoter, into an ectopic locus of the genome.
In all our experiments, the complemented strain showed only partial recovery of the wt phenotypes. To understand the reason for this finding, we measured whiB5 expression in both the wt and complemented strains but failed to show any relevant difference between the two strains. Of course, it is still possible that differences in the fine-tuning of whiB5 expression, which might be due to unrecognized regulatory regions far upstream of the promoter, are responsible for the only partial recovery of the wt phenotypes.
Finally, to determine the role of WhiB5 in virulence, the whiB5 mutant was used to infect mice in progressive and chronic disease models of infection. In both models, the whiB5 mutant was attenuated. In the progressive disease model, animals infected with the mutant strain showed longer survival with slightly smaller bacillary loads than those of mice infected with the parental or complemented strain ( Fig. 2A and B) . Moreover, mice infected with the mutant strain showed more lung inflammatory consolidation than those infected with the other strains, as well as larger granulomas (Fig. 2C ) and higher expression levels of proinflammatory cytokines such as IFN-␥ and TNF-␣, along with less IL-4 production (Fig. 4) , suggesting a larger protective immune response in these animals. This cytokine profile was confirmed and extended by immunohistochemistry and automated morphometry, which showed a significantly higher percentage of immunostained cells reactive to the proinflammatory cytokines TNF-␣ and IFN-␥ and a smaller amount of inflammatory cells immunoreactive to the anti-inflammatory cytokines IL-10, IL-4, and TGF-␤ in the lungs of mice infected with the mutant strain ( Fig. 3 and 5) . Thus, these data suggest that the lack of WhiB5 produces some antigenic modifications which induce more inflammation and larger granulomas, constituted essentially of Th1 cells and activated macrophages, in coexistence with smaller numbers of Th2 and Treg cells, as denoted by the lower percentages of IL-10-and TGF-immunostained lymphocytes, allowing more efficient clearance of the bacilli.
Since WhiB5 controls the expression of members of two type VII secretion systems, we hypothesize that some antigens exported by ESX-2 or ESX-4 could have an immunosuppressing function. However, the decreased virulence of the whiB5 mutant cannot be attributed solely to the downregulation of sigM, since in a previous study it was shown that a sigM mutant was not attenuated in mice (1) .
Chronic infection induced by lower-level bacillus administration resulted in smaller bacillary burdens in mice infected with the mutant strain (Fig. 6) , associated with more IFN-␥ and iNOS expression (Fig. 7) , than in animals infected with the wt or complemented strain, as previously shown in the progressive infection model. However, infection with the mutant strain resulted in less TNF-␣ expression (Fig. 7) , while it resulted in more expression of this cytokine in the progressive disease model. This discrepancy between the two models of infection might result from the very small amount of bacteria infecting the lungs in the chronic infection model or from the different genetic backgrounds of the mice used for these two models of infection. Interestingly, when chronic infection was reactivated by corticosterone administration, the mutant strain was not able to resume growth, while the lung bacterial burdens of mice infected with the wt or complemented strain increased significantly, suggesting that WhiB5 might be involved with bacillary proliferation during reactivation (Fig. 6) . To the best of our knowledge, this is the first M. tuberculosis mutant shown to have this phenotype. This finding is particularly interesting because the mechanism of reactivation of M. tuberculosis is still unknown. It is possible that the reduced metabolic activity of the whiB5 mutant under nutrient-limiting conditions, together with the presence of GSNO and GSH in macrophages, does not allow the bacteria to resume growth after pressure of the immune response is relieved by corticosterone, underscoring the importance of both the nutritional status and the production of GSNO and/or GSH by macrophages in the establishment and maintenance of chronic infection. Moreover, since WhiB5 controls the expression of two type VII secretion systems (whose physiologic role is still completely unknown), it is possible to hypothesize that some antigens exported by ESX-2 or ESX-4 might be involved in immunomodulation or in quorumsensing mechanisms necessary for reactivation. Based on these findings, we believe that further analysis of the whiB5 mutant's behavior and physiology during chronic infection might help to shed some light on the mechanism of reactivation of M. tuberculosis.
